Gordon McQueen, Brain Injury
Digest more
A popular technique for studying brain disorders, known as lesion network mapping (LNM), appears to have a fundamental limitation. This is the conclusion of neuroscientists from Vrije Universiteit Amsterdam and the University of Queensland (Australia) after an extensive analysis of more than 200 studies.
5don MSN
OHSU researchers identify key trigger behind brain disorder often mistaken for mental illness
Some serious brain disorders begin with symptoms that are easy to misinterpret. A person may become confused, forgetful or paranoid and be treated for mental illness before doctors realize the underlying problem isn’t psychological at all.
A new study reveals a critical vulnerability in a brain receptor targeted by a rare autoimmune disease. Researchers have moved a step closer to new treatments for a rare and often devastating autoimmune disease that interferes with how the brain communicates.
New research links inflammation to mental health symptoms. Personalized care using brain and immune data could improve symptoms when standard treatments don’t work.
Billy Joel made his first appearance since being diagnosed with a brain disorder and relied on a cane to help walk.
Massachusetts Institute of Technology researchers are working on microscopic, wireless chips that can travel through the bloodstream and self-implant in a targeted region of the brain. Photo courtesy of Sarkar Lab, MIT/HealthDay News Imagine a brain ...
Alzheimer's disease has long been thought to be irreversible, but new research using a mouse model offers hope.
No standard treatments for the sometimes deadly disorder have been developed, but that may change due to the newly published research.
Acute systemic inflammation has long been suspected to trigger harmful processes within the brain, contributing to neurodegenerative disorders such as Alzheimer's and Parkinson's disease. A new study published online in the Journal of Proteome Research on ...
Micro- and nanoplastics are increasingly detected in human tissues, including the brain, and experimental evidence suggests they can interact with biological pathways central to Parkinson’s disease pathology.